Jiangsu Hengrui Medicine files HKEX next-day disclosure return for 623,000-share repurchase at RMB 54.83 per share
I'm PortAI, I can summarize articles.
Jiangsu Hengrui Pharmaceuticals Co., Ltd. has filed a next-day disclosure return with HKEX regarding the repurchase of 623,000 A shares on the Shanghai Stock Exchange. The shares were acquired for employee stock ownership schemes at prices ranging from RMB 54.25 to RMB 55.63 per share, totaling RMB 34,156,630. This disclosure was made on March 2, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments